Friday, April 28, 2017 9:20:34 PM
The offering is consummation on the uplisting. Read the last line below I copied this from the s1. They have already filed, we meet the requirements.
Our Common Stock is quoted on the OTCQB® Venture Marketplace (the “OTCQB”) under the symbol “BLSP” (temporary symbol “BLSPD” commencing on March 24, 2017, through the earlier of the date on which our stock begins trading on The NASDAQ Capital Market or April 21, 2017, indicating that the Reverse Stock Split (as defined below) has occurred). On March 24, 2017, the closing sale price of our Common Stock was $5.80 per share. Currently, there is no established public trading market in the On January 19, 2017, we filed an application to have our Common Stock and the Warrants listed on The NASDAQ Capital Market under the symbols “BLSP” and “BLSPW”, respectively. No assurance can be given that our application will be approved. Listing of our Common Stock on The NASDAQ Capital Market is a condition to consummation of the Offering.
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM